Mio Yasushi, Bienengraeber Martin W, Marinovic Jasna, Gutterman David D, Rakic Mladen, Bosnjak Zeljko J, Stadnicka Anna
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Anesthesiology. 2008 Apr;108(4):612-20. doi: 10.1097/ALN.0b013e318167af2d.
Clinical trials suggest that anesthetic-induced preconditioning (APC) produces cardioprotection in humans, but the mechanisms of APC and significance of aging for APC in humans are not well understood. Here, the impact of age on the role of two major effectors of APC, mitochondria and sarcolemmal adenosine triphosphate-sensitive potassium (sarcKATP) channels, in preconditioning of the human atrial myocardium were investigated.
Right atrial appendages were obtained from adult patients undergoing cardiac surgery and assigned to mid-aged (MA) and old-aged (OA) groups. APC was induced by isoflurane in isolated myocardium and isolated cardiomyocytes. Mitochondrial oxygen consumption measurements, myocyte survival testing, and patch clamp techniques were used to investigate mitochondrial respiratory function and sarcKATP channel activity.
After in vitro APC with isoflurane, the respiratory function of isolated mitochondria was better preserved after hypoxia-reoxygenation stress in MA than in OA. In isolated intact myocytes, APC significantly decreased oxidative stress-induced cell death in MA but not in OA, and isoflurane protection from cell death was attenuated by the sarcKATP channel inhibitor HMR-1098. Further, the properties of single sarcKATP channels were similar in MA and OA, and isoflurane sensitivity of pinacidil-activated whole cell KATP current was no different between MA and OA myocytes.
Anesthetic-induced preconditioning with isoflurane decreases stress-induced cell death and preserves mitochondrial respiratory function to a greater degree in MA than in OA myocytes; however, sarcKATP channel activity is not differentially affected by isoflurane. Therefore, effectiveness of APC in humans may decrease with advancing age partly because of altered mitochondrial function of myocardial cells.
临床试验表明,麻醉诱导预处理(APC)对人类具有心脏保护作用,但APC的机制以及衰老对人类APC的意义尚未完全明确。在此,研究了年龄对APC的两个主要效应器——线粒体和肌膜三磷酸腺苷敏感性钾(sarcKATP)通道在人类心房肌预处理中的作用的影响。
从接受心脏手术的成年患者获取右心耳,并分为中年(MA)组和老年(OA)组。在离体心肌和离体心肌细胞中用异氟烷诱导APC。采用线粒体氧消耗测量、心肌细胞存活测试和膜片钳技术研究线粒体呼吸功能和sarcKATP通道活性。
在体外使用异氟烷进行APC后,MA组离体线粒体在缺氧复氧应激后的呼吸功能比OA组保存得更好。在离体完整心肌细胞中,APC显著降低了MA组而非OA组氧化应激诱导的细胞死亡,并且sarcKATP通道抑制剂HMR - 1098减弱了异氟烷对细胞死亡的保护作用。此外,MA组和OA组单个sarcKATP通道的特性相似,MA组和OA组心肌细胞中匹那地尔激活的全细胞KATP电流对异氟烷的敏感性无差异。
异氟烷诱导的APC在MA组心肌细胞中比OA组心肌细胞更大程度地降低应激诱导的细胞死亡并保存线粒体呼吸功能;然而,sarcKATP通道活性不受异氟烷的差异影响。因此,APC在人类中的有效性可能会随着年龄增长而降低,部分原因是心肌细胞线粒体功能改变。